Lisette Hilton


Pattern of metastatic spread impacts whether enzalutamide plus ADT improves PFS in prostate cancer

January 28, 2021

"Here we show that there are clear benefits in delaying radiographic progression or death, [PSA] progression, and other outcomes in the largest groups of men with metastatic hormone-sensitive prostate cancer and lymph node and bone metastases,” says Andrew Armstrong, MD.